+Vote!
www.OSIR.org.in (Free subscription) | 28/11/2008
Looking for stocks that should benefit now that Senator Obama is officially President-Elect Obama? Many investors believe that liberals negatively impact stock markets in general and that the only companies to benefit from a liberal adminstration are Source: www.bloggingstocks.com UPDATE 1-Celgene stem cell therapy gets FDA nod for human trials - ReutersNov 10 (Reuters) [...]
+Vote!
BloggingStocks (Free subscription) | 27/11/2008
Filed under: Newsletters , Stocks to Buy "The medical arena has long been my favorite sectors; perhaps the best opportunities within the medical sector will be with companies who provide life-saving products for the treatment of serious diseases," says Dave Dyer . In The Dave Dyer Newsletter , he explains, "That is why Celgene (NASDAQ: CELG ) is an excellent choice in this economy." Here's his look...
+Vote!
www.OSIR.org.in (Free subscription) | 27/11/2008
Rodman & Renshaw Annual Global Investment Conference - Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and Source: www.pr-inside.com UPDATE 1-Celgene stem cell therapy gets FDA nod for human trials - ReutersNov 10 (Reuters) - Biotechnology giant Celgene [...]
+Vote!
www.OSIR.org.in (Free subscription) | 23/11/2008
2008-11-09 23:53:01 - Rodman & Renshaw Annual Global Investment Conference - Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory Source: www.pr-inside.com UPDATE 1-Celgene stem cell therapy gets FDA nod for human trials - ReutersNov 10 (Reuters) - Biotechnology giant [...]
+Vote!
Business Wire (Free subscription) | 17/11/2008
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced its presentation at the Lazard Capital Markets 5th Annual Healthcare Conference on Wednesday, November 19, 2008 at 9:30 a.m. EST will be
+Vote!
www.OSIR.org.in (Free subscription) | 16/11/2008
Nov 10 (Reuters) - Biotechnology giant Celgene Corp (CELG.O: Quote , Profile , Research , Stock Buzz ) said it received approval from U.S. health regulators to start human testing of its experimental stem-cell therapy for the treatment of Crohn’s Source: www.reuters.com
+Vote!
www.OSIR.org.in (Free subscription) | 15/11/2008
Hot Healthcare Stocks JMP Healthcare Focus Conference Achillion works on Hepatitis C Spectrum discusses 1st Oncology NDA Celgene seeks #1 Source: stocks.forbes.com OSIR | X PRIZE FoundationType Post Author Replies Last updated; No posts available. Source: www.googlelunarxprize.org www.OSIR.org.inCELEBRATING EGYPT TODAY S 25th anniversary last month brought back memories of the days when poor Egyptian...
+Vote!
Business Wire (Free subscription) | 13/11/2008
NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue.
+Vote!
www.OSIR.org.in (Free subscription) | 12/11/2008
Nov 10 (Reuters) - Biotechnology giant Celgene Corp (CELG.O: Quote , Profile , Research , Stock Buzz ) said it received approval from U.S. health regulators to start human testing of its experimental stem-cell therapy for the treatment of Crohn’s Source: www.reuters.com Refer to a friend - PR InsideRodman & Renshaw Annual Global Investment [...]
+Vote!
www.OSIR.org.in (Free subscription) | 12/11/2008
Health stocks lagged Thursday but fared better than the broader market, with the Nasdaq and Amex biotechnology indices down 1.6% and 1.7%, respectively. Among individual stocks, notable movers were: Simcere ( SCR Quote - Cramer on SCR - Stock Picks Source: www.thestreet.com UPDATE 1-Celgene stem cell therapy gets FDA nod for human trials - [...]
+Vote!
Red Orbit (Free subscription) | 11/11/2008
Celgene Cellular Therapeutics, a wholly owned subsidiary of Celgene Corporation, has announced that the FDA has accepted the company's investigational new drug application to initiate a clinical trial using PDA001, an immunomodulatory therapy utilizing human placenta-derived stem cells obtained via the company's proprietary processes.
+Vote!
Business Wire (Free subscription) | 11/11/2008
BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl (NASDAQ: CELG) today announced that clinical investigators from leading hematology research
+Vote!
Business Wire (Free subscription) | 07/11/2008
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced its presentation at the 2008 Credit Suisse Annual Health Care Conference on Wednesday, November 12,
+Vote!
I LOVE MONEY (Free subscription) | 04/11/2008
Also, ag and fertilizer stocks could profit from Obama pushing ethanol. Cramer added that Celgene (CELG) and Gilead (GILD)… Visit The Cramer Report to read the rest of the bMad Money/b recap and get the rest of Jim Cramer’s investing b…/b Source:TheCramerReport.com#39;s bMad Money/b Recap - November 3, 2008
